Post-approval studies (Phase 4)Study completedNCT00125567What this trial is testingStalevo in Early Wearing-Off PatientsWho this might be right forIdiopathic Parkinson's Disease Orion Corporation, Orion Pharma 223
Not applicableStudy completedNCT05127057What this trial is testingProactive and Integrated Management and Empowerment in Parkinson's Disease (PRIME-UK): A New Model of Care (PRIME-RCT)Who this might be right forParkinsonism University of Bristol 214
Early research (Phase 1)WithdrawnNCT05832775What this trial is testingStudy to Assess the Safety of MRx0029 or MRx0005 Compared to Placebo, in People With Parkinson'sWho this might be right forIdiopathic Parkinson Disease 4D pharma plc
Not applicableNot Yet RecruitingNCT07622303What this trial is testingDepression, Anxiety and Sleep in Parkinson's DiseaseWho this might be right forParkinson's Disease Sohag University 100
Early research (Phase 1)Looking for participantsNCT07195825What this trial is testingA Clinical Study to Evaluate the Safety, and Tolerability of BBM-P002 in the Treatment of Parkinson's DiseaseWho this might be right forPD Shanghai Xinzhi BioMed Co., Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT03305809What this trial is testingLY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)Who this might be right forLewy Body Dementia Eli Lilly and Company 344
Testing effectiveness (Phase 2)Study completedNCT03652363What this trial is testingGDNF in ideopathicParkinsons DiseaseWho this might be right forIdiopathic Parkinson Disease North Bristol NHS Trust 42
Not applicableNot Yet RecruitingNCT07838675What this trial is testingMediPD: An Online Mediterranean Diet Program for People Living With Parkinson's DiseaseWho this might be right forParkinson Disease, Idiopathic Queen's University, Belfast 120
Testing effectiveness (Phase 2)Study completedNCT01221948What this trial is testingVercise Implantable Stimulator for Treating Parkinson's DiseaseWho this might be right forIdiopathic Parkinson's Disease Boston Scientific Corporation 53
Not applicableUnknownNCT02494908What this trial is testingEvidence of Neuroplasticity After Performing a Cognitive Task in Idiopathic Parkinson's Disease PatientsWho this might be right forParkinson Disease Dr. Sharon Hassin 80
Early research (Phase 1)Study completedNCT05924243What this trial is testingInvestigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease.Who this might be right forParkinson Disease Hoffmann-La Roche 60
Not applicableStudy completedNCT02248168What this trial is testingPost Marketing Surveillance And Special Surveillance for Mirapex® Tablet in Patients With Idiopathic Parkinson's DiseaseWho this might be right forParkinson Disease Boehringer Ingelheim 1,449
Large-scale testing (Phase 3)Study completedNCT01187966What this trial is testingEfficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's DiseaseWho this might be right forParkinson's Disease Newron Pharmaceuticals SPA 669
Testing effectiveness (Phase 2)UnknownNCT00498758What this trial is testingThe APOS System: Effects on Gait, Mobility and QOL in Patients With Parkinson's DiseaseWho this might be right forIdiopathic Parkinson's Disease Tel-Aviv Sourasky Medical Center 60
Not applicableStudy completedNCT02248181What this trial is testingPost Marketing Surveillance Study of Sifrol® in Patients With Idiopathic Parkinson's DiseaseWho this might be right forParkinson Disease Boehringer Ingelheim 442
Testing effectiveness (Phase 2)Active Not RecruitingNCT04459052What this trial is testingFDOPA PET and Nutritional Support in Parkinson's DiseaseWho this might be right forParkinson DiseaseIdiopathic Parkinson Disease Thomas Jefferson University 50
Post-approval studies (Phase 4)Ended earlyNCT03968744What this trial is testingEffect of Safinamide on Sleep Quality in Patients With Parkinson's DiseaseWho this might be right forIdiopathic Parkinson's Disease (at Later Stage) Alain Kaelin 11
Not applicableStudy completedNCT02231294What this trial is testingThe Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's DiseaseWho this might be right forParkinson Disease Boehringer Ingelheim 1,464
Testing effectiveness (Phase 2)Ended earlyNCT03720418What this trial is testingStudy of OXB-102 (AXO-Lenti-PD) in Patients With Bilateral, Idiopathic Parkinson's DiseaseWho this might be right forParkinson Disease Sio Gene Therapies 6
Post-approval studies (Phase 4)Study completedNCT00141518What this trial is testingLong-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic ImpactWho this might be right forAdvanced Idiopathic Parkinson's Disease AbbVie (prior sponsor, Abbott) 77